The global market for Fungal Nail Infections Treatment Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fungal Nail Infections Treatment Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Fungal Nail Infections Treatment Drug by region & country, by Type, and by Application.

The Fungal Nail Infections Treatment Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Nail Infections Treatment Drug.

Market Segmentation

Scope of Fungal Nail Infections Treatment Drug - Market Report

Report Metric	Details
Report Name	Fungal Nail Infections Treatment Drug - Market
CAGR	5%
Segment by Type:	Topical Oral Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Bausch Health Companies, Inc, Bayer AG, Cipla Limited, Sun Pharmaceutical Industries Ltd, GlaxoSmithKline PLC (GSK), Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Novartis AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fungal Nail Infections Treatment Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Fungal Nail Infections Treatment Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Fungal Nail Infections Treatment Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Fungal Nail Infections Treatment Drug - Market report?

Ans: The main players in the Fungal Nail Infections Treatment Drug - Market are Abbott Laboratories, Bausch Health Companies, Inc, Bayer AG, Cipla Limited, Sun Pharmaceutical Industries Ltd, GlaxoSmithKline PLC (GSK), Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Novartis AG

What are the Application segmentation covered in the Fungal Nail Infections Treatment Drug - Market report?

Ans: The Applications covered in the Fungal Nail Infections Treatment Drug - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Fungal Nail Infections Treatment Drug - Market report?

Ans: The Types covered in the Fungal Nail Infections Treatment Drug - Market report are Topical, Oral, Others

1 Market Overview

1.1 Fungal Nail Infections Treatment Drug Product Introduction

1.2 Global Fungal Nail Infections Treatment Drug Market Size Forecast

1.3 Fungal Nail Infections Treatment Drug Market Trends & Drivers

1.3.1 Fungal Nail Infections Treatment Drug Industry Trends

1.3.2 Fungal Nail Infections Treatment Drug Market Drivers & Opportunity

1.3.3 Fungal Nail Infections Treatment Drug Market Challenges

1.3.4 Fungal Nail Infections Treatment Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Fungal Nail Infections Treatment Drug Players Revenue Ranking (2023)

2.2 Global Fungal Nail Infections Treatment Drug Revenue by Company (2019-2024)

2.3 Key Companies Fungal Nail Infections Treatment Drug Manufacturing Base Distribution and Headquarters

2.4 Key Companies Fungal Nail Infections Treatment Drug Product Offered

2.5 Key Companies Time to Begin Mass Production of Fungal Nail Infections Treatment Drug

2.6 Fungal Nail Infections Treatment Drug Market Competitive Analysis

2.6.1 Fungal Nail Infections Treatment Drug Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Fungal Nail Infections Treatment Drug Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Nail Infections Treatment Drug as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Topical

3.1.2 Oral

3.1.3 Others

3.2 Global Fungal Nail Infections Treatment Drug Sales Value by Type

3.2.1 Global Fungal Nail Infections Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Fungal Nail Infections Treatment Drug Sales Value, by Type (2019-2030)

3.2.3 Global Fungal Nail Infections Treatment Drug Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Others

4.2 Global Fungal Nail Infections Treatment Drug Sales Value by Application

4.2.1 Global Fungal Nail Infections Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Fungal Nail Infections Treatment Drug Sales Value, by Application (2019-2030)

4.2.3 Global Fungal Nail Infections Treatment Drug Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Fungal Nail Infections Treatment Drug Sales Value by Region

5.1.1 Global Fungal Nail Infections Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Fungal Nail Infections Treatment Drug Sales Value by Region (2019-2024)

5.1.3 Global Fungal Nail Infections Treatment Drug Sales Value by Region (2025-2030)

5.1.4 Global Fungal Nail Infections Treatment Drug Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

5.2.2 North America Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

5.3.2 Europe Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

5.4.2 Asia Pacific Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

5.5.2 South America Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

5.6.2 Middle East & Africa Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Fungal Nail Infections Treatment Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Fungal Nail Infections Treatment Drug Sales Value

6.3 United States

6.3.1 United States Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

6.3.2 United States Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Fungal Nail Infections Treatment Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

6.4.2 Europe Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Fungal Nail Infections Treatment Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

6.5.2 China Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Fungal Nail Infections Treatment Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

6.6.2 Japan Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Fungal Nail Infections Treatment Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

6.7.2 South Korea Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Fungal Nail Infections Treatment Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Fungal Nail Infections Treatment Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Fungal Nail Infections Treatment Drug Sales Value, 2019-2030

6.9.2 India Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Fungal Nail Infections Treatment Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Profile

7.1.2 Abbott Laboratories Main Business

7.1.3 Abbott Laboratories Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.1.4 Abbott Laboratories Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.1.5 Abbott Laboratories Recent Developments

7.2 Bausch Health Companies, Inc

7.2.1 Bausch Health Companies, Inc Profile

7.2.2 Bausch Health Companies, Inc Main Business

7.2.3 Bausch Health Companies, Inc Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.2.4 Bausch Health Companies, Inc Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.2.5 Bausch Health Companies, Inc Recent Developments

7.3 Bayer AG

7.3.1 Bayer AG Profile

7.3.2 Bayer AG Main Business

7.3.3 Bayer AG Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.3.4 Bayer AG Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.3.5 Cipla Limited Recent Developments

7.4 Cipla Limited

7.4.1 Cipla Limited Profile

7.4.2 Cipla Limited Main Business

7.4.3 Cipla Limited Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.4.4 Cipla Limited Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.4.5 Cipla Limited Recent Developments

7.5 Sun Pharmaceutical Industries Ltd

7.5.1 Sun Pharmaceutical Industries Ltd Profile

7.5.2 Sun Pharmaceutical Industries Ltd Main Business

7.5.3 Sun Pharmaceutical Industries Ltd Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.5.4 Sun Pharmaceutical Industries Ltd Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.5.5 Sun Pharmaceutical Industries Ltd Recent Developments

7.6 GlaxoSmithKline PLC (GSK)

7.6.1 GlaxoSmithKline PLC (GSK) Profile

7.6.2 GlaxoSmithKline PLC (GSK) Main Business

7.6.3 GlaxoSmithKline PLC (GSK) Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.6.4 GlaxoSmithKline PLC (GSK) Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.6.5 GlaxoSmithKline PLC (GSK) Recent Developments

7.7 Pfizer, Inc

7.7.1 Pfizer, Inc Profile

7.7.2 Pfizer, Inc Main Business

7.7.3 Pfizer, Inc Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.7.4 Pfizer, Inc Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.7.5 Pfizer, Inc Recent Developments

7.8 Teva Pharmaceutical Industries Ltd

7.8.1 Teva Pharmaceutical Industries Ltd Profile

7.8.2 Teva Pharmaceutical Industries Ltd Main Business

7.8.3 Teva Pharmaceutical Industries Ltd Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.8.4 Teva Pharmaceutical Industries Ltd Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments

7.9 Merck & Co., Inc

7.9.1 Merck & Co., Inc Profile

7.9.2 Merck & Co., Inc Main Business

7.9.3 Merck & Co., Inc Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.9.4 Merck & Co., Inc Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.9.5 Merck & Co., Inc Recent Developments

7.10 Novartis AG

7.10.1 Novartis AG Profile

7.10.2 Novartis AG Main Business

7.10.3 Novartis AG Fungal Nail Infections Treatment Drug Products, Services and Solutions

7.10.4 Novartis AG Fungal Nail Infections Treatment Drug Revenue (US$ Million) & (2019-2024)

7.10.5 Novartis AG Recent Developments

8 Industry Chain Analysis

8.1 Fungal Nail Infections Treatment Drug Industrial Chain

8.2 Fungal Nail Infections Treatment Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Fungal Nail Infections Treatment Drug Sales Model

8.5.2 Sales Channel

8.5.3 Fungal Nail Infections Treatment Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Bausch Health Companies Inc.

Bayer

Cipla Ltd

Sun Pharmaceutical Industries Ltd.

Glaxosmithkline PLC (GSK)

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Merck& Co. Inc

Novartis

List of Tables

Table 1. Fungal Nail Infections Treatment Drug Market Trends

Table 2. Fungal Nail Infections Treatment Drug Market Drivers & Opportunity

Table 3. Fungal Nail Infections Treatment Drug Market Challenges

Table 4. Fungal Nail Infections Treatment Drug Market Restraints

Table 5. Global Fungal Nail Infections Treatment Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Fungal Nail Infections Treatment Drug Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Fungal Nail Infections Treatment Drug Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Fungal Nail Infections Treatment Drug Product Type

Table 9. Key Companies Time to Begin Mass Production of Fungal Nail Infections Treatment Drug

Table 10. Global Fungal Nail Infections Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Nail Infections Treatment Drug as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Fungal Nail Infections Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Fungal Nail Infections Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Fungal Nail Infections Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Fungal Nail Infections Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Fungal Nail Infections Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Fungal Nail Infections Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Fungal Nail Infections Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Fungal Nail Infections Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Fungal Nail Infections Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Fungal Nail Infections Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Fungal Nail Infections Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Fungal Nail Infections Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Fungal Nail Infections Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Fungal Nail Infections Treatment Drug Sales Value by Region (2019-2024) & (%)

Table 27. Global Fungal Nail Infections Treatment Drug Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Fungal Nail Infections Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Fungal Nail Infections Treatment Drug Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Fungal Nail Infections Treatment Drug Sales Value, (2025-2030) & (US$ Million)

Table 31. Abbott Laboratories Basic Information List

Table 32. Abbott Laboratories Description and Business Overview

Table 33. Abbott Laboratories Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 34. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Abbott Laboratories (2019-2024)

Table 35. Abbott Laboratories Recent Developments

Table 36. Bausch Health Companies, Inc Basic Information List

Table 37. Bausch Health Companies, Inc Description and Business Overview

Table 38. Bausch Health Companies, Inc Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 39. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Bausch Health Companies, Inc (2019-2024)

Table 40. Bausch Health Companies, Inc Recent Developments

Table 41. Bayer AG Basic Information List

Table 42. Bayer AG Description and Business Overview

Table 43. Bayer AG Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 44. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Bayer AG (2019-2024)

Table 45. Bayer AG Recent Developments

Table 46. Cipla Limited Basic Information List

Table 47. Cipla Limited Description and Business Overview

Table 48. Cipla Limited Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 49. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Cipla Limited (2019-2024)

Table 50. Cipla Limited Recent Developments

Table 51. Sun Pharmaceutical Industries Ltd Basic Information List

Table 52. Sun Pharmaceutical Industries Ltd Description and Business Overview

Table 53. Sun Pharmaceutical Industries Ltd Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 54. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Sun Pharmaceutical Industries Ltd (2019-2024)

Table 55. Sun Pharmaceutical Industries Ltd Recent Developments

Table 56. GlaxoSmithKline PLC (GSK) Basic Information List

Table 57. GlaxoSmithKline PLC (GSK) Description and Business Overview

Table 58. GlaxoSmithKline PLC (GSK) Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 59. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of GlaxoSmithKline PLC (GSK) (2019-2024)

Table 60. GlaxoSmithKline PLC (GSK) Recent Developments

Table 61. Pfizer, Inc Basic Information List

Table 62. Pfizer, Inc Description and Business Overview

Table 63. Pfizer, Inc Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 64. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Pfizer, Inc (2019-2024)

Table 65. Pfizer, Inc Recent Developments

Table 66. Teva Pharmaceutical Industries Ltd Basic Information List

Table 67. Teva Pharmaceutical Industries Ltd Description and Business Overview

Table 68. Teva Pharmaceutical Industries Ltd Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 69. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Teva Pharmaceutical Industries Ltd (2019-2024)

Table 70. Teva Pharmaceutical Industries Ltd Recent Developments

Table 71. Merck & Co., Inc Basic Information List

Table 72. Merck & Co., Inc Description and Business Overview

Table 73. Merck & Co., Inc Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 74. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Merck & Co., Inc (2019-2024)

Table 75. Merck & Co., Inc Recent Developments

Table 76. Novartis AG Basic Information List

Table 77. Novartis AG Description and Business Overview

Table 78. Novartis AG Fungal Nail Infections Treatment Drug Products, Services and Solutions

Table 79. Revenue (US$ Million) in Fungal Nail Infections Treatment Drug Business of Novartis AG (2019-2024)

Table 80. Novartis AG Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Fungal Nail Infections Treatment Drug Downstream Customers

Table 84. Fungal Nail Infections Treatment Drug Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Fungal Nail Infections Treatment Drug Product Picture

Figure 2. Global Fungal Nail Infections Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Fungal Nail Infections Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Fungal Nail Infections Treatment Drug Report Years Considered

Figure 5. Global Fungal Nail Infections Treatment Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Fungal Nail Infections Treatment Drug Revenue in 2023

Figure 7. Fungal Nail Infections Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Topical Picture

Figure 9. Oral Picture

Figure 10. Others Picture

Figure 11. Global Fungal Nail Infections Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Fungal Nail Infections Treatment Drug Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospital

Figure 14. Product Picture of Clinic

Figure 15. Product Picture of Others

Figure 16. Global Fungal Nail Infections Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Fungal Nail Infections Treatment Drug Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Fungal Nail Infections Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Fungal Nail Infections Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Fungal Nail Infections Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Fungal Nail Infections Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Fungal Nail Infections Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Fungal Nail Infections Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Fungal Nail Infections Treatment Drug Sales Value (%), (2019-2030)

Figure 29. United States Fungal Nail Infections Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Fungal Nail Infections Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Fungal Nail Infections Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Fungal Nail Infections Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 35. China Fungal Nail Infections Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 37. China Fungal Nail Infections Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Fungal Nail Infections Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Fungal Nail Infections Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Fungal Nail Infections Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Fungal Nail Infections Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Fungal Nail Infections Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Fungal Nail Infections Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 47. India Fungal Nail Infections Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Fungal Nail Infections Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 49. India Fungal Nail Infections Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 50. Fungal Nail Infections Treatment Drug Industrial Chain

Figure 51. Fungal Nail Infections Treatment Drug Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions